E-LIB Suche - Ergebnisse für: Pivot, X.

1

Abemaciclib plus a nonsteroidal aromatase inhibitor as init..:

Goetz, M.P. ; Toi, M. ; Huober, J....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

2

A propensity score–weighted study comparing a two- versus f..:

Bischoff, H. ; Bigot, C. ; Moinard-Butot, F....
Breast Cancer Research and Treatment. 198 (2022) 1 - p. 23-29 , 2022

Link: https://doi.org/10.1007/..

3

Survie globale et sans récidive locale en cas de radiothéra..:

Kuntz, L. ; Le Fèvre, C. ; Hild, C....
Gynécologie Obstétrique Fertilité & Sénologie. 49 (2021) 4 - p. 255-265 , 2021

Link: https://doi.org/10.1016/..

4

Delayed care for patients with newly diagnosed cancer due t..:

Blay, J.Y. ; Boucher, S. ; Le Vu, B....
ESMO Open. 6 (2021) 3 - p. 100134 , 2021

Link: https://doi.org/10.1016/..

5

Real-world study on HR+, HER2−, node-positive, high-risk ea..:

Pivot, X. ; Chartier, F. ; Chouaki, N....
The Breast. 56 (2021) - p. S37-S38 , 2021

Link: https://doi.org/10.1016/..

6

Adjuvant T-DM1 versus trastuzumab in patients with residual..:

Mamounas, E.P. ; Untch, M. ; Mano, M.S....
Annals of Oncology. 32 (2021) 8 - p. 1005-1014 , 2021

Link: https://doi.org/10.1016/..

7

Real-world clinical profile, treatment patterns and patient..:

Davie, A. ; Cuyun Carter, G. ; Rider, A....
ESMO Open. 6 (2021) 4 - p. 100226 , 2021

Link: https://doi.org/10.1016/..

8

5-year follow-up of the safety, tolerability and efficacy o..:

Gligorov, J. ; Pivot, X. ; Ataseven, B....
The Breast. 56 (2021) - p. S21-S22 , 2021

Link: https://doi.org/10.1016/..

9

Irradiation axillaire prophylactique « de diffusion » dans ..:

Schmitt, M. ; Pin, Y. ; Pflumio, C....
Cancer/Radiothérapie. 25 (2021) 2 - p. 191-199 , 2021

Link: https://doi.org/10.1016/..

10

PCN4 Overall Survival in Post-Menopausal Women with HR+/HER..:

Hirst, A. ; Davie, A. ; Cuyun Carter, G....
Value in Health. 23 (2020) - p. S421 , 2020

Link: https://doi.org/10.1016/..

11

3-year follow-up of a phase III study comparing SB3 (trastu..:

Pivot, X. ; Bondarenko, I. ; Dvorkin, M....
The Breast. 44 (2019) - p. S68 , 2019

Link: https://doi.org/10.1016/..

12

Systemic high-dose intravenous methotrexate in patients wit..:

Bazan, F. ; Dobi, E. ; Royer, B....
BMC Cancer. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

13

The open-label, multinational, multicenter, Phase IIIB umbr..:

Pivot, X. ; Poole, C. ; Martín, M....
European Journal of Cancer. 92 (2018) - p. S105-S106 , 2018

Link: https://doi.org/10.1016/..

14

A phase III study comparing SB3 (a proposed trastuzumab bio..:

Pivot, X. ; Bondarenko, I. ; Nowecki, Z....
European Journal of Cancer. 93 (2018) - p. 19-27 , 2018

Link: https://doi.org/10.1016/..

15

Prognostic and predictive indicators in early-stage breast ..:

Curtit, E. ; Mansi, L. ; Maisonnette-Escot, Y...
European Journal of Surgical Oncology (EJSO). 43 (2017) 5 - p. 921-930 , 2017

Link: https://doi.org/10.1016/..